Persistent recipient-derived human adenovirus (HAdV)-specific T cells promote HAdV control after allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplant. 2017 Apr;52(4):609-611. doi: 10.1038/bmt.2016.321. Epub 2017 Jan 9.

Authors

R E Schultze-Florey^{1

2}, S Tischer^{2

3}, W Kühnau⁴, A Heim⁵, B Eiz-Vesper^{2

3}, B Maecker-Kolhoff^{1

2}

Affiliations

¹ Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
² Integrated Research and Treatment Center Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany.
³ Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany.
⁴ Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
⁵ Institute of Virology, Hannover Medical School, Hannover, Germany.

PMID: 28067874
DOI: 10.1038/bmt.2016.321

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adenoviridae / immunology*
Adenoviridae Infections* / immunology
Adenoviridae Infections* / therapy
Adoptive Transfer*
Allografts
Hematopoietic Stem Cell Transplantation*
Humans
Infant
Male
T-Lymphocytes* / immunology
T-Lymphocytes* / transplantation
alpha-Mannosidosis* / immunology
alpha-Mannosidosis* / therapy